New Chief Technology Officer Appointed at Envestnet
October 24, 2025 - 04:08
Envestnet has announced the appointment of Bhaskar Peddhapati as its new Chief Technology Officer. Peddhapati brings a wealth of experience to the role, having previously served at Cotality, a data and software company that was formerly known as CoreLogic. His background in technology and data management is expected to enhance Envestnet's capabilities in delivering innovative solutions to its clients.
The decision to bring Peddhapati on board reflects Envestnet's commitment to strengthening its technological infrastructure and improving service offerings. As the financial landscape continues to evolve, the company aims to leverage Peddhapati's expertise to drive advancements in its technology platform.
Peddhapati's leadership is anticipated to play a crucial role in guiding Envestnet through a period of transformation, as the firm seeks to meet the growing demands of registered investment advisors (RIAs) and enhance their operational efficiencies. This strategic move underscores Envestnet's focus on remaining competitive in the rapidly changing financial technology sector.
MORE NEWS
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...